Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. [electronic resource] by
- Del-Aguila, J L
- Beitelshees, A L
- Cooper-Dehoff, R M
- Chapman, A B
- Gums, J G
- Bailey, K
- Gong, Y
- Turner, S T
- Johnson, J A
- Boerwinkle, E
Producer: 20140908
In:
The pharmacogenomics journal vol. 14
Availability: No items available.
|
|
|
7.
|
Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension. [electronic resource] by
- Johnson, A D
- Gong, Y
- Wang, D
- Langaee, T Y
- Shin, J
- Cooper-Dehoff, R M
- Schork, N J
- Binkley, P
- Pepine, C J
- Johnson, J A
- Sadee, W
Producer: 20090106
In:
Clinical pharmacology and therapeutics vol. 85
Availability: No items available.
|
|
|
8.
|
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians. [electronic resource] by
- Hamadeh, I S
- Shahin, M H
- Lima, S M
- Oliveira, F
- Wilson, L
- Khalifa, S I
- Langaee, T Y
- Cooper-DeHoff, R M
- Cavallari, L H
- Johnson, J A
Producer: 20161114
In:
Clinical and translational science vol. 9
Availability: No items available.
|
|
|
9.
|
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order. [electronic resource] by
- Johnson, J A
- Gong, Y
- Bailey, K R
- Cooper-DeHoff, R M
- Chapman, A B
- Turner, S T
- Schwartz, G L
- Campbell, K
- Schmidt, S
- Beitelshees, A L
- Boerwinkle, E
- Gums, J G
Producer: 20091104
In:
Clinical pharmacology and therapeutics vol. 86
Availability: No items available.
|
|
|
10.
|
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation? [electronic resource] by
- Chang, S W
- Gong, Y
- McDonough, C W
- Langaee, T Y
- Nasiri Kenari, N
- Beitelshees, A L
- Gums, J G
- Chapman, A B
- Turner, S T
- Johnson, J A
- Cooper-DeHoff, R M
Producer: 20161226
In:
Clinical and translational science vol. 9
Availability: No items available.
|
|
|
11.
|
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression. [electronic resource] by
- Duarte, J D
- Turner, S T
- Tran, B
- Chapman, A B
- Bailey, K R
- Gong, Y
- Gums, J G
- Langaee, T Y
- Beitelshees, A L
- Cooper-Dehoff, R M
- Boerwinkle, E
- Johnson, J A
Producer: 20131231
In:
The pharmacogenomics journal vol. 13
Availability: No items available.
|
|
|
12.
|
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate. [electronic resource] by
- Hamadeh, I S
- Langaee, T Y
- Dwivedi, R
- Garcia, S
- Burkley, B M
- Skaar, T C
- Chapman, A B
- Gums, J G
- Turner, S T
- Gong, Y
- Cooper-DeHoff, R M
- Johnson, J A
Producer: 20140922
In:
Clinical pharmacology and therapeutics vol. 96
Availability: No items available.
|
|
|
13.
|
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. [electronic resource] by
- Chang, S-W
- McDonough, C W
- Gong, Y
- Johnson, T A
- Tsunoda, T
- Gamazon, E R
- Perera, M A
- Takahashi, A
- Tanaka, T
- Kubo, M
- Pepine, C J
- Johnson, J A
- Cooper-DeHoff, R M
Producer: 20181211
In:
The pharmacogenomics journal vol. 18
Availability: No items available.
|
|
|
14.
|
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. [electronic resource] by
- Wilke, R A
- Ramsey, L B
- Johnson, S G
- Maxwell, W D
- McLeod, H L
- Voora, D
- Krauss, R M
- Roden, D M
- Feng, Q
- Cooper-Dehoff, R M
- Gong, L
- Klein, T E
- Wadelius, M
- Niemi, M
Producer: 20120904
In:
Clinical pharmacology and therapeutics vol. 92
Availability: No items available.
|
|
|
15.
|
Characterization of adult obesity in Florida using the OneFlorida clinical research consortium. [electronic resource] by
- Filipp, S L
- Cardel, M
- Hall, J
- Essner, R Z
- Lemas, D J
- Janicke, D M
- Smith, S R
- Nadglowski, J
- Troy Donahoo, W
- Cooper-DeHoff, R M
- Nelson, D R
- Hogan, W R
- Shenkman, E A
- Gurka, M J
Publication details: Obesity science & practice Aug 2018
In:
Obesity science & practice vol. 4
Availability: No items available.
|
|
|
16.
|
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study. [electronic resource] by
- Vandell, A G
- McDonough, C W
- Gong, Y
- Langaee, T Y
- Lucas, A M
- Chapman, A B
- Gums, J G
- Beitelshees, A L
- Bailey, K R
- Johnson, R J
- Boerwinkle, E
- Turner, S T
- Cooper-DeHoff, R M
- Johnson, J A
Producer: 20141224
In:
Journal of internal medicine vol. 276
Availability: No items available.
|
|
|
17.
|
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes. [electronic resource] by
- Rotroff, D M
- Shahin, M H
- Gurley, S B
- Zhu, H
- Motsinger-Reif, A
- Meisner, M
- Beitelshees, A L
- Fiehn, O
- Johnson, J A
- Elbadawi-Sidhu, M
- Frye, R F
- Gong, Y
- Weng, L
- Cooper-DeHoff, R M
- Kaddurah-Daouk, R
Producer: 20160119
In:
CPT: pharmacometrics & systems pharmacology vol. 4
Availability: No items available.
|
|
|
18.
|
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. [electronic resource] by
- Ramsey, L B
- Johnson, S G
- Caudle, K E
- Haidar, C E
- Voora, D
- Wilke, R A
- Maxwell, W D
- McLeod, H L
- Krauss, R M
- Roden, D M
- Feng, Q
- Cooper-DeHoff, R M
- Gong, L
- Klein, T E
- Wadelius, M
- Niemi, M
Producer: 20141124
In:
Clinical pharmacology and therapeutics vol. 96
Availability: No items available.
|
|
|
19.
|
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment. [electronic resource] by
- Karnes, J H
- McDonough, C W
- Gong, Y
- Vo, T T
- Langaee, T Y
- Chapman, A B
- Gums, J G
- Beitelshees, A L
- Bailey, K R
- Del-Aguila, J L
- Boerwinkle, E A
- Pepine, C J
- Turner, S T
- Johnson, J A
- Cooper-DeHoff, R M
Producer: 20140501
In:
The pharmacogenomics journal vol. 13
Availability: No items available.
|
|
|
20.
|
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. [electronic resource] by
- Luzum, J A
- Pakyz, R E
- Elsey, A R
- Haidar, C E
- Peterson, J F
- Whirl-Carrillo, M
- Handelman, S K
- Palmer, K
- Pulley, J M
- Beller, M
- Schildcrout, J S
- Field, J R
- Weitzel, K W
- Cooper-DeHoff, R M
- Cavallari, L H
- O'Donnell, P H
- Altman, R B
- Pereira, N
- Ratain, M J
- Roden, D M
- Embi, P J
- Sadee, W
- Klein, T E
- Johnson, J A
- Relling, M V
- Wang, L
- Weinshilboum, R M
- Shuldiner, A R
- Freimuth, R R
Producer: 20170822
In:
Clinical pharmacology and therapeutics vol. 102
Availability: No items available.
|